SGH
Sivik Global Healthcare Portfolio holdings
AUM
$224M
This Quarter Return
+1.72%
1 Year Return
+5.3%
3 Year Return
+45.33%
5 Year Return
+103.79%
10 Year Return
+430.94%
AUM
$252M
AUM Growth
+$252M
(-6.9%)
Cap. Flow
-$23.7M
Cap. Flow
% of AUM
-9.38%
Top 10 Holdings %
Top 10 Hldgs %
29.07%
Holding
74
New
14
Increased
11
Reduced
28
Closed
13
Top Buys
| 1 |
Becton Dickinson
BDX
|
$8.19M |
| 2 |
UnitedHealth
UNH
|
$7.32M |
| 3 |
Pfizer
PFE
|
$6.5M |
| 4 |
Tenet Healthcare
THC
|
$3.51M |
| 5 |
Neurocrine Biosciences
NBIX
|
$3.38M |
Top Sells
| 1 |
Novo Nordisk
NVO
|
$7.06M |
| 2 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
$6.08M |
| 3 |
WCG
Wellcare Health Plans, Inc.
WCG
|
$4.28M |
| 4 |
Viatris
VTRS
|
$4.25M |
| 5 |
Biogen
BIIB
|
$3.55M |
Sector Composition
| 1 | Healthcare | 95.16% |
| 2 | Energy | 1.18% |
| 3 | Utilities | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Grifois
GRFS
$6.78B
| $2.11M | 0.51% |
+100,020
| New | +$2.11M |
|
52
Teladoc Health
TDOC
$1.37B
| $1.99M | 0.48% |
+30,000
| New | +$1.99M |
|
|
AKRX
53
DELISTED
Akorn, Inc.
AKRX
| $1.96M | 0.47% |
380,000
+14,300
| +4% | +$73.6K |
|
|
NVRO
54
DELISTED
NEVRO CORP.
NVRO
| $1.95M | 0.47% |
30,000
-20,000
| -40% | -$1.3M |
|
55
Revvity
RVTY
$10.5B
| $1.93M | 0.47% |
+20,000
| New | +$1.93M |
|
56
Illumina
ILMN
$15.8B
| $1.84M | 0.45% |
5,000
-7,500
| -60% | -$2.76M |
|
|
HRC
57
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
| $1.57M | 0.38% |
+15,000
| New | +$1.57M |
|
58
Agios Pharmaceuticals
AGIO
$2.19B
| $1.5M | 0.36% |
30,000
+5,000
| +20% | +$249K |
|
59
Acadia Pharmaceuticals
ACAD
$4.38B
| $1.34M | 0.32% |
+50,000
| New | +$1.34M |
|
60
AbbVie
ABBV
$372B
| – | – |
-42,500
| Closed | -$3.43M |
|
|
61
Biogen
BIIB
$19.4B
| – | – |
-15,000
| Closed | -$3.55M |
|
62
DexCom
DXCM
$29.5B
| – | – |
-12,500
| Closed | -$1.49M |
|
63
Fresenius Medical Care
FMS
$15.1B
| – | – |
-50,000
| Closed | -$2.03M |
|
|
64
Novo Nordisk
NVO
$251B
| – | – |
-135,000
| Closed | -$7.06M |
|
65
Puma Biotechnology
PBYI
$254M
| – | – |
-40,000
| Closed | -$1.55M |
|
66
Perrigo
PRGO
$3.27B
| – | – |
-40,000
| Closed | -$1.93M |
|
67
Qiagen
QGEN
$10.1B
| – | – |
-80,000
| Closed | -$3.25M |
|
68
Teva Pharmaceuticals
TEVA
$21.1B
| – | – |
-215,000
| Closed | -$3.37M |
|
|
69
Viatris
VTRS
$12.3B
| – | – |
-150,000
| Closed | -$4.25M |
|
|
ALXN
70
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| – | – |
-45,000
| Closed | -$6.08M |
|
|
VAR
71
DELISTED
Varian Medical Systems, Inc.
VAR
| – | – |
-19,000
| Closed | -$2.69M |
|
|
EAS
72
DELISTED
ENERGY EAST CORP (HOLD CO)
EAS
| – | – |
-20,000
| Closed | -$1.73M |
|